Insulet (PODD) Retained Earnings (2010 - 2026)
Insulet's (PODD) quarterly Retained Earnings came in at $5.6 million in Q1 2026, up 193.33% YoY from $1.9 million in Q1 2025, and down 99.56% on a QoQ basis from $1.3 billion in Q4 2025.
Insulet (PODD) Retained Earnings (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Retained Earnings data on file, last reported at $5.6 million in Q1 2026.
- Quarterly Retained Earnings rose 193.33% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 193.33% YoY) and the FY2025 annual result came in at $1.3 billion, up 3063.52% from the prior year.
- Retained Earnings declined to $5.6 million in Q1 2026, from $1.3 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.3 billion in Q4 2025 to a low of -$561.1 million in Q1 2022.
- A 5-year average of $273.6 million and a median of $15.4 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 30170.59% — and 2023, when it tumbled 7505.56%.
- Tracing PODD's Retained Earnings over 5 years: stood at $20.0 million in 2022, then soared by 5413.0% to $1.1 billion in 2023, then tumbled by 96.35% to $40.3 million in 2024, then jumped by 3063.52% to $1.3 billion in 2025, then tumbled by 99.56% to $5.6 million in 2026.
- The last three Retained Earnings figures came in at $5.6 million (Q1 2026), $1.3 billion (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Insulet | 10.42 Bn | 9.88 Bn | 562.60 Mn | 1.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Bn |
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 1.27 Bn |
| Sep 30, 2025 | 12.20 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | -6.00 Mn |
| Dec 31, 2024 | 40.30 Mn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 1.10 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | -533.20 Mn |
| Mar 31, 2023 | 15.90 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 7.20 Mn |
| Mar 31, 2022 | -561.10 Mn |
| Dec 31, 2021 | -2.20 Mn |
| Sep 30, 2021 | -3.40 Mn |